Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models

EMBO J. 2023 Oct 4;42(19):e113246. doi: 10.15252/embj.2022113246. Epub 2023 Aug 14.

Abstract

Neuronal hyperactivity is a key feature of early stages of Alzheimer's disease (AD). Genetic studies in AD support that microglia act as potential cellular drivers of disease risk, but the molecular determinants of microglia-synapse engulfment associated with neuronal hyperactivity in AD are unclear. Here, using super-resolution microscopy, 3D-live imaging of co-cultures, and in vivo imaging of lipids in genetic models, we found that spines become hyperactive upon Aβ oligomer stimulation and externalize phosphatidylserine (ePtdSer), a canonical "eat-me" signal. These apoptotic-like spines are targeted by microglia for engulfment via TREM2 leading to amelioration of Aβ oligomer-induced synaptic hyperactivity. We also show the in vivo relevance of ePtdSer-TREM2 signaling in microglia-synapse engulfment in the hAPP NL-F knock-in mouse model of AD. Higher levels of apoptotic-like synapses in mice as well as humans that carry TREM2 loss-of-function variants were also observed. Our work supports that microglia remove hyperactive ePtdSer+ synapses in Aβ-relevant context and suggest a potential beneficial role for microglia in the earliest stages of AD.

Keywords: Abeta oligomers; Alzheimer's disease; microglia; pruning; synapses.

MeSH terms

  • Alzheimer Disease* / genetics
  • Amyloid beta-Peptides / genetics
  • Animals
  • Disease Models, Animal
  • Humans
  • Membrane Glycoproteins / genetics
  • Mice
  • Microglia
  • Receptors, Immunologic / genetics
  • Synapses

Substances

  • Amyloid beta-Peptides
  • TREM2 protein, human
  • Membrane Glycoproteins
  • Receptors, Immunologic